Stimcell Energetics (STME) Net Cash Flow (QoQ) (2012 - 2026)
Stimcell Energetics (STME) Net Cash Flow (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -190.48% |
| Nov 30, 2025 | 592.63% |
| Aug 31, 2025 | -206.22% |
| May 31, 2025 | 128.42% |
| Feb 28, 2025 | -300.07% |
| Nov 30, 2024 | 158.83% |
| Aug 31, 2024 | 36.75% |
| May 31, 2024 | -163.51% |
| Feb 29, 2024 | 261.50% |
| Nov 30, 2023 | 12.46% |
| Aug 31, 2023 | -144.47% |
| May 31, 2023 | 944.29% |
| Feb 28, 2023 | -222.06% |
| Nov 30, 2022 | 160.09% |
| Aug 31, 2022 | -126.09% |
| May 31, 2022 | 4.17% |
| Feb 28, 2022 | 74.03% |
| Nov 30, 2021 | -161.04% |
| Aug 31, 2021 | 810.07% |
| May 31, 2021 | -459.02% |